Go Pro
NASDAQ:SNES

Senestech Q2 2026 Earnings Report

Senestech logo
$1.43 +0.03 (+2.14%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$1.43 0.00 (-0.28%)
As of 07/13/2026 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Senestech EPS Results

Actual EPS
N/A
Consensus EPS
-$0.37
Beat/Miss
N/A
One Year Ago EPS
N/A

Senestech Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.60 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Senestech Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Thursday, August 6, 2026
Conference Call Time
5:00PM ET

Conference Call Resources

Senestech Earnings Headlines

They proved it worked in '76. Then buried it.
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the project. Unocal and Texaco did the same. All three buried the results because it threatened their core business. Now one company has spent sixty years developing what Big Oil refused to touch. Google locked in a 15-year contract, Bill Gates wrote a $100 million check, and on August 18th the government hands it a competitive edge no other energy source receives.tc pixel
See More Senestech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Senestech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Senestech and other key companies, straight to your email.

About Senestech

Senestech (NASDAQ:SNES) (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction. Administered through tamper-resistant bait stations, ContraPest delivers a proprietary formulation designed to lower fertility in target populations of Norway rats and roof rats. SenesTech complements its product offering with consultation and support services, assisting customers in designing monitoring programs, interpreting data, and implementing integrated pest management strategies tailored to municipal, commercial, and industrial settings.

Founded in 2001 and headquartered in Prescott, Arizona, SenesTech secured EPA approval for ContraPest in 2016, marking a milestone as the first fertility control agent for rodents available on the market. Since then, the company has expanded its distribution network across North America, serving food processing facilities, hospitality venues, healthcare institutions, warehouses, and municipal vector control agencies. SenesTech continues to pursue research and development of next-generation fertility control technologies and to explore potential applications in emerging global pest and wildlife management markets.

Led by an executive team with backgrounds in biotechnology, environmental science, and pest management, SenesTech is governed by a board of directors comprising industry experts in commercial product development and regulatory affairs. The company’s management structure supports ongoing collaboration with regulatory agencies and commercial partners to advance innovative solutions that address public health and sustainability concerns associated with rodent infestations.

View Senestech Profile